Nanobiotix raises 85 million for innovative treatment development
French biotech firm Nanobiotix raises 85 million euros to fund research into cancer and neurodegenerative diseases.
Published 10sem1 sourceNotable
Lire en français
≈ 19s
The fact
This major investment supports the Parisian startup's strategy to commercialize its therapeutic promises.
The fundraising consolidates Nanobiotix's position among French champions of biomedical innovation.
Click the link to read an article on the topic: